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Background: 
The aim of this study was to compare the efficacy of ketorolac, paracetamol, and paracetamol plus morphine 
on pain relief after thyroidectomy.
Methods: 
Eighty patients were randomly allocated to one of the 4 groups: normal saline (group C), ketorolac 30 mg 
(group K), paracetamol 1 g (group P), and paracetamol 700 mg plus morphine 3 mg (group PM). Each regimen 
was administered intravenously (IV) 30 min. before the end of surgery. If pain was not relieved, patients received 
an IV bolus of pethidine hydrochloride 25 mg. Pain intensity using a visual analogue scale (VAS) was recorded 
at 0.5, 1, 2, 4, and 6 hr after the end of surgery.
Results: 
VAS at 0.5 and 1 hr after the end of surgery were significantly lower in group K, group P , and group PM 
than in group C (P ＜ 0.05). The number of patients receiving pethidine hydrochloride at 0.5 and 1 hr after 
the end of surgery was significantly lower in group K, group P , and group PM than in group C (P ＜ 0.05). 
There was no significant difference among the groups in the incidences of adverse events associated with study 
medications and patient satisfaction (P  ＞ 0.05).
Conclusions: 
Paracetamol 1 g IV possesses a similar analgesic efficacy to ketorolac 30 mg IV after thyroidectomy. 
Paracetamol may represent an alternative to ketorolac for pain prevention after mildly to moderately painful 
surgery in situations where the use of NSAIDs is unsuitable. (Korean  J  Pain  2010;  23:  124-130)
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Table 1. Demographic Data
　
Group C
(n = 20)
Group K
(n = 20)
Group P
(n = 20)
Group PM
(n = 20)
Age (yr)
Height (cm)
Weight (kg)
Duration of operation (min)
Duration of anesthesia (min)
 46.3 ± 9.5
157.1 ± 3.9 
 58.8 ± 7.5
  71.3 ± 16.8
 105.5 ± 14.1
 46.1 ± 9.9
158.1 ± 3.9 
 59.0 ± 7.6
  72.5 ± 15.4
 108.5 ± 15.2
 44.7 ± 7.3
158.6 ± 3.9 
 57.0 ± 7.9
  74.5 ± 18.9
 109.0 ± 21.4
 45.2 ± 9.4
159.5 ± 3.1
 56.2 ± 6.1
  72.8 ± 14.6
 108.8 ± 15.2
Value are mean ± SD. There was no significant difference among the groups (P ＞ 0. 05) .  Gr oup C:  nor mal  sal i ne,  Gr oup K:  ket or ol ac
30 mg, Group P: paracetamol 1 g, Group PM: paracetamol 700 mg + morphine 3 mg.
INTRODUCTION
    Postoperative pain hinders the recovery from an op-
eration and causes various stress reactions [1]: it can neg-
atively affect the cardiovascular system and the respira-
tory system by stimulating the sympathetic nervous sys-
tem and causing hypoxia in body organs, as well as pneu-
monia and other pulmonary complications resulting from 
r e s p i r a t o r y  f a i l u r e .  T h e  r e a c t i o n s  i n  t h e  c a r d i o v a s c u l a r  
system include an increase of heart rate, stroke volume, 
my ocardial oxy gen consumption, and peripheral vascular 
resistance [2]. In addition, it can bring about complications 
such as phlebothrombosis, pulmonary embolism, respira-
tory failure, and myocardial infarction [3].
    In addition to opioids, non-steroidal anti-inflammatory 
drugs (NSAIDs) are frequently used in postoperative pain 
control [4,5]. NSAIDs such as ketorola are able to effec-
tively control mild and moderate postoperative pain [6,7], 
but long-term administration of them may cause hemor-
rhaging  at  the  operated  part,  gastrointestinal  bleeding, 
and  renal  insufficiency  [8].  Recently,  paracetamol,  an 
acetaminophen v enous drug, was dev eloped (Perfalgan
Ⓡ, 
BMS Pharmaceutical Korea), and it has a similar analgesic 
effect as that of NSAIDs, but with less side effects [9,10]. 
Paracetamol is a useful pharmaceutical that can be applied 
for the treatment when immediate venous injection is re-
quired due to the pain or high fever, or when the side ef-
fects of NSAIDs concerned, and when venous injection is 
the only possible treatment for mild and moderate pain, 
e s p e c i a l l y  f o r  p o s t o p e r a t i v e  p a i n  a n d  f e v e r .  I n  a d d i t i o n , 
since paracetamol has an opioid-sparing effect when it is 
used together with a small quantity of opioid, it can show 
good analgesic effect while minimizing the side effects of 
opioid, such as respiratory depression, bradycardia, and 
hypoxia.
    Therefore, to study the effects of paracetamol, which 
might be substituted for NSAIDs or opiods but with less 
side effects, we compared the postoperative analgesic ef-
fects and the side effects by medicating paracetamol 1 g 
or ketorolac 30 mg, each of the drugs independently, or 
by medicating paracetamol 700 mg and morphine 3 mg 
together for thyroidectomy patients.
MATERIALS  AND  METHODS
    Conforming to the ethics regulations of the hospital 
ethics committee, this study was conducted after giving an 
explanation to the patients and obtaining their consent. 
The subjects of this study were the 80 female patients, 
aged between 20 and 60, who were scheduled to undertake 
regular surgery under general anesthesia, had already un-
dergone a total thyroidectomy without endoscopy and ro-
bot-aided procedure, and were at the Class 1 and 2 of the 
American  Society  of  Anesthesiologists  Physical  Status 
classification. Those who had a history of drug abuse, hy-
persensitivity to drugs, diseases in the cardiovascular sys-
tem, respiratory system, kidneys or liver, those who had 
been medicated with drugs that could affect the analgesic 
effect before the operation, and those who were regarded 
inappropriate for the clinical test for other reasons were 
excluded from the subjects. There was no significant dif-
ference among the subjects in the 4 groups of age, height, 
weight, and the duration of anesthesia (Table 1).
    The subject patients were divided into 4 groups, 20 
patients in each. An intravenous injection of paracetamol 
1 g was performed for 15 minutes, 30 minutes before the 
end of the operation to P Group (n = 20), ketorolac 30 mg 
to K Group (n = 20), paracetamol 700 mg and morphine 126 Korean J Pain Vol. 23, No. 2, 2010
Table 2. P a i n  S c o r e s  ( V AS ) 
Group C
(n = 20)
Group K
(n = 20)
Group P
(n = 20)
Group PM
(n = 20)
30 min
1 h
2 h
4 h
6 h
6.2 ± 1.2
5.9 ± 1.0
3.8 ± 1.1
3.5 ± 1.3
3.4 ± 1.0
 4.0 ± 1.2*
 3.8 ± 1.2*
3.3 ± 0.9
3.2 ± 1.1
3.3 ± 1.3
 4.1 ± 1.1*
 3.9 ± 1.3*
3.3 ± 1.1
3.2 ± 1.0
3.4 ± 1.2
 4.1 ± 1.2*
 3.9 ± 1.1*
3.4 ± 1.1
3.3 ± 1.0
3.3 ± 1.1
Value are mean ± SD. Group C: normal saline, Group K: ketorolac
30 mg, Group P: paracetamol 1 g, Group PM: paracetamol 700 
mg ＋ morphine 3 mg. *P ＜ 0.05 compared with group C.
Fig. 1. Comparison of postoperative VAS for pain. VAS at 
0.5 and 1 hr after the end of surgery were significantly 
lower in group K, group P, and group PM than in group C.
Value are mean ± SD. Group C: normal saline, Group K: 
ketorolac 30 mg, Group P: paracetamol 1 g, Group PM: 
paracetamol 700 mg ＋ morphine 3 mg. *P ＜ 0.05 com-
pared with group C.
3 mg to PM Group (n = 20), and normal saline to C Group 
(n = 20).
    All the patients underwent alimentary abstinence for 
8 hours before the operation, and midazolam 2 mg and 
glycopyrrolate 0.2 mg were injected through the muscle 30 
minutes  before  the  operation  as  the  preanesthetic 
medication.  The  induction  was  performed  by  the  intra-
venous injection of propofol 2 mg/kg. After loss of con-
sciousness and sufficient muscle relaxation with rocuro-
nium 0.8 mg/kg, the endotracheal intubation followed. The 
anesthesia was maintained with 2 L/min of O2 and N2O, 
as well as sevoflurane 1.5-3.0 vol%. The tidal volume and 
respiratory rate were regulated to keep the positive end 
expiratory  carbon  dioxide  pressure  at  30-35  mmHg. 
Opiods that could affect the postoperative analgesic effect 
w e r e  n o t  u s e d .  R a m o s e t r o n  ( N a s e a
Ⓡ,  Astellas  Pharma 
Korea) 0.3 mg was intravenously injected just before fin-
ishing the operation to prevent nausea and vomiting. The 
effect  of  muscle  relaxant  was  reversed  by  using  pyr-
idostigmine 15 mg, glycopyrrolate 0.2 mg, and atropine 0.5 
mg after the end of the operation.
    The duration of the anesthesia was recorded as the 
time from the induction to the removal of the endotracheal 
tube, and the duration of the operation was recorded as 
the time from the initiation of the skin incision to the end 
of the skin suture. The anesthesiologists, who were blinded 
to the patients' groupings, visited the patients after 30 
minutes and 1 hour in the postoperative recovery room, 
and after 2, 4, and 6 hours at the ward; they surveyed 
the degree of pain (VAS, visual analogue scale: 10 cm), side 
e f f e c t s ,  s u c h  a s  n a u s e a ,  v o m i t i n g ,  h e a d a c h e ,  s e d a t i o n ,  
d i z z i n e s s ,  a n d  r e s p i r a t o r y  d e p r e s s i o n ,  a n d  t h e  p a t i e n t s '  
overall degree of satisfaction regarding the pain control. 
The patients' overall degree of satisfaction regarding the 
pain control was evaluated for a comparison among the 
groups on a 4-point scale: 1 point for poor, 2 points for 
fair, 3 points for good, and 4 points for excellent. When 
the patients wanted treatment because the pain was not 
regulated and the patient could not endure the pain, an 
intravenous injection of pethidine hydrochloride 25 mg was 
performed and a repeated injection was allowed for the 
same patient who wanted more pain control.
    The statistical process was conducted with SPSS ver-
sion 13.0 (SPSS Inc. Chicago, IL, USA) and the comparison 
among the groups were analyzed by an ANOV A test and 
a Pearson chi-square test. All the measurements were ex-
pressed as ''mean ± standard deviation'' and the cases 
with the P value less than 0.05 were judged to be statisti-
cally significant.
RESULTS
    The V ASs of C Group were 6.2 ± 1.2 and 5.9 ± 1.0 
at 30 minutes and 1 hour after the operation, respectively. 
The V ASs of K Group, P Group, and PM Group were 4.0 
± 1.2, 4.1 ± 1.1, and 4.1 ± 1.2, respectively, at 30 minutes 
after the operation, and 3.8 ± 1.2, 3.9 ± 1.3, and 3.9 ± 
1.1, respectively, at 1 hour after the operation. The V ASs 
of C Group were significantly higher than those of K Group, SY Lee, et al / Analgesic Efficacy of Paracetamol 127
Table 3. Incidences of Uses of Rescue Drugs During Each Period
　
Group C
(n = 20)
Group K
(n = 20)
Group P
(n = 20)
Group PM
(n = 20)
0-0.5 h
0.5-1 h
1-2 h
2-4 h
4-6 h
6 (30)
8 (40)
2 (10)
1 (5)
2 (10)
1 (5)*
 2 (10)*
1 (5)
0 (0)
2 (10)
 1 (5)*
 1 (5)*
1 (5)
1 (5)
 2  (10)
  2 (10)*
 1 (5)*
 2 (10)
0 (0)
1 (5)
Data are numbers (%) of patients. Group C: normal saline, Group
K: ketorolac 30 mg, Group P: paracetamol 1 g, Group PM: 
paracetamol 700 mg ＋ morphine 3 mg. *P ＜ 0.05 compared with
group C.
Table 4. Patient Satisfaction at Six Hours after Surgery Using a 
Verbal Rating Scale
　
Group C
(n = 20)
Group K
(n = 20)
Group P
(n = 20)
Group PM
(n = 20)
Poor
Fair
Good
Excellent
4 (20)
7 (35)
8 (40)
1 (5)
1 (5)
 5 (25)
11 (55)
 3 (15)
2 (10)
6 (30)
9 (45)
3 (15)
2 (10)
6 (30)
10 (50)
2 (10)
Data are numbers (%) of patients. There was no significant 
difference among the groups (P ＞ 0.05). Group C: normal saline,
Group K: ketorolac 30 mg, Group P: paracetamol 1 g, Group PM:
paracetamol 700 mg ＋ morphine 3 mg.
Table 5. Incidences of Adverse Events
　
Group C
(n = 20)
Group K
(n = 20)
Group P
(n = 20)
Group PM
(n = 20)
Nausea & Vomiting
Dizziness
Sedation
Headache
1
0
0
3
1
0
1
4
2
1
1
3
2
1
1
4
Data are numbers of patients. There was no significant difference
among the groups (P ＞ 0.05). Group C: normal saline, Group K: 
ketorolac 30 mg, Group P: paracetamol 1 g, Group PM: para-
cetamol 700 mg ＋ morphine 3 mg.
P Group, and PM Group (P ＜ 0.05). There was no sig-
nificant difference among the groups in the VAS at 2 hours, 
4 hours, and 6 hours after the operation. The VAS tended 
to decrease in all the 4 groups as the time passed after 
the operation (Table 2, Fig. 1).
    The number of cases where pethidine hydrochloride, 
the additional analgesic, was used was 6 (30%) and 8 (40%) 
at 30 minutes and 1 hour after the operation, respectively, 
in C Group. The number of additional analgesic injection 
in K Group, P Group, and PM Group was 1 (5%), 1 (5%), 
and 2 (10%) at 30 minutes, and 2 (10%), 1 (5%), and 1 (5%), 
respectively, at 2 hours after the operation. Thus, the use 
o f  p e t h i d i n e  h y d r o c h l o r i d e  w a s  s i g n i f i c a n t l y  (P ＜ 0.05) 
more in C Group than K Group, P Group, and PM Group 
(Table 3).
    The patients' overall degree of satisfaction in C Group, 
K Group, P Group, and PM Group was evaluated as ''poor 
(1 point)'' by 4 (20%), 1 (5%), 2 (10%), and 2 (10%), re-
spectively, “fair (2 points)'' by 7 (35%), 5 (25%), 6 (30%), 
and 6 (30%), respectively, ''good (3 points)'' by 8 (40%), 11 
(55%), 9 (45%), and 10 (50%), respectively, and ''excellent 
( 4  p o i n t s ) ' '  b y  1  ( 5 % ) ,  3  ( 1 5 % ) ,  3  ( 1 5 % )  a n d  2  ( 1 0 % ) ,  
respectively.  Although  the  overall  degree  of  satisfaction 
was lower in C group than in K Group, P Group, and PM 
G r o u p ,  i t  w a s  n o t  s i g n i f i c a n t l y  d i f f e r e n t  a m o n g  t h e  4  
groups (Table 4).
    The overall occurrence of nausea and vomiting was 
not significantly different among the 4 groups. No sig-
nificant difference was found among the 4 groups in the 
occurrence of side effects related to the medication, such 
as dizziness, sedation, respiratory depression, and head-
ache (Table 5).
DISCUSSION
    Postoperative pain causes not only physical suffering 
but also mental fear and anxiety, affecting the recovery 
procedure of the patients by bringing about limited ex-
ercise, declined respiratory capability, and pulmonary com-
p l i c a t i o n s  [ 1 1 ] .  H e n c e ,  e f f e c t i v e  c o n t r o l  o f  p o s t o p e r a t i v e 
pain can provide a lot of advantages, including a reduction 
of the complications and early discharge from the hospital. 
Thyroidectomy is now an operation that is frequently per-
formed thanks to the development of diagnosis technology, 
but it makes the patients uncomfortable, like other oper-
ations, due to the pain and the sequela caused by the pain.
    The analgesics that are now used for postoperative 
p a i n  c o n t r o l  i n c l u d e  o p i o i d s  a n d  N S A I D s .  K e t o r o l a ,  a  
N S A I D ,  s h o w s  a  p o w e r f u l  a n a l g e s i c ,  a n t i - i n f l a m m a t o r y , 
and antipyretic effect by inhibiting cyclooxygenase I and 
cyclooxygenase II. Since ketorola can be administrated in 
a parenteral manner, and it does not seriously suppress 128 Korean J Pain Vol. 23, No. 2, 2010
the respiratory and cardiovascular systems, it has been 
used f or the purpose of postoperativ e pain con trol, in-
dependently or by mixing it with opioids through the pa-
tient-  controlled  analgesia  equipment  [12,13].  However, 
there have reports that intermittent intravenous injection 
or  intramuscular  injection  of  ketorolac  elongated  the 
bleeding time and reduced the platelet aggregation capa-
bility [14,15]. Thus, the effect of ketorolac on the intra-
operative  and  postoperative  hemorrhage  is  still  a 
controversy. Splinter et al. [16] reported that preoperative 
administration of ketorolac 1 mg/kg to the children under-
going tonsillectomy significantly increased the amount of 
intraoperative bleeding compared with the group to which 
codeine was administrated. In contrast, Power et al. [17] 
reported that an intramuscular injection of ketorolac 30 
m g  d u r i n g  t h e  i n d u c t i o n  o f  a  p a t i e n t  u n d e r g o i n g  c h o l -
ecystectomy increased the duration of bleeding and the 
platelet  aggregation  capability,  but  not  the  quantity  of 
bleeding. The potential risk of side effects by ketorolac is 
increased when it is medicated in a high dose, used for 
5 days or longer, or when it is used on patients who are 
vulnerable to drugs, such as elderly patients [18]. Thus, to 
prevent side effects, it should be used in an appropriate 
dose for a short period of time, or after checking whether 
the patients have a contraindication or not.
    On the other hand, though acetaminophen has been 
universally used for pain treatment by oral administration, 
it co ul d n o t be ap p li ed to patien ts w h o ha d to un d er go 
postoperative  alimentary  abstinence.  However,  the  re-
cently-developed paracetamol is an acetaminophen for in-
t r a v e n o u s  i n j e c t i o n ,  a n d  i t s  u s e  f o r  p o s t o p e r a t i v e  p a i n  
c o n t r o l  i s  g r a d u a l l y  i n c r e a s i n g .  T h e  m o d u s  o p e r a n d i  o f  
paracetamol has not yet been clearly revealed, but it has 
been reported that paracetamol shows a powerful anti-
pyretic and analgesic effect by inhibiting cyclooxygenase 
I and cyclooxygenase II, like NSAIDs, and inhibiting pros-
taglandin  synthesis;  additionally,  it  has  weak  anti-in-
flammatory effect and does not cause platelet function de-
clination or gastric mucosal damage, and in such ways is 
different from NSAIDs [19-21]. Based on the functions of 
paracetamol that are different from those of NSAIDs, 1 hy-
pothesis assumes that it might act on cyclooxygenase III 
and other mechanisms. Also, suppression of nitric oxide 
synthesis  and  supraspinal  serotonin-dependent  anti-
nociceptive mechanism are studied at present [22,23].
    Propacetamol, N-acetyl-paramino-phenol diethyl ami-
noacetic ester, the prodrug of paracetamol, is produced by 
the esterification of paracetamol and hydrolyzed by non-
specific  plasma esterase.  Thus, 2  g of  propacetamol  is 
pharmacokinetically equivalent to 1 g of paracetamol. Many 
studies  regarding  the  effect  of  propacetamol  on  post-
operative pain control have been reported: Varrassi et al. 
[24] reported that 2 g of propacetamol showed a similar 
analgesic effect to that of 30 mg of ketorolac in a gyneco-
l o g i c a l  o p e r a t i o n .  Z h o u  e t  a l .  [ 1 0 ]  r e p o r t e d  t h a t  2  g  o f 
propacetamol and 30 mg of ketorolac showed an almost 
identical effect in acute pain control after a total hip re-
placement or total knee replacement. Van Aken et al. [25] 
claimed that propacetamol 2 g and morphine 10 mg showed 
a similar analgesic effect after a dental operation, just as 
paracetamol 1 g, ketorolac 30 mg, and paracetamol 700 
mg ＋ morphine 3 mg showed a similar analgesic effect 
in this study.
    According to Moller et al. [26], the onset time of pr op-
acetamol for intravenous injection was 3 to 5 minutes, and 
the maximum analgesic effect was found 15 to 45 minutes 
after the injection. They also reported that, since the drug 
action duration was 4 to 6 hours, the analgesic effect could 
be maintained up to 6 hours after the operation, showing 
a  similar  pharmacodynamic  property  with  that  of 
ketorolac. In this study, considering time of the maximum 
analgesic effect of the drug, the analgesics were injected 
30 minutes before the end of the operation to maximize 
the analgesic effect. Moderate analgesic effect was shown 
similarly for 6 hours after the operation in the K Group, 
P Group, and PM Group.
    The postoperative pain evaluation, V AS, in this study 
was higher in C Group than in K Group, P Group, and PM 
Group at 30 minutes and 1 hour after the operation, but 
there was no significant difference in V AS at 2 hours, 4 
hours, and 6 hours. This is assumed to be the results of 
an additional administration of the analgesic carried out to 
s i g n i f i c a n t l y  m o r e  p a t i e n t s ,  6  ( 3 0 % )  a n d  8  ( 4 0 % )  i n  C 
Group, than those in K Group, P Group, and PM Group, 
w i t h i n  3 0  m i n u t e s  a n d  1  h o u r  a f t e r  t h e  o p e r a t i o n ,  
respectively.  Thus,  no  significant  difference  was  found 
among the groups at the times after 1 hour.
    F or an evaluation of the patients' overall degree of 
satisfaction regarding the pain control, the 4-point scale 
created by Zhou et al. [10] was employed. A measure of 
dissatisfaction was found in C Group at the times 30 mi-
nutes and 1 hour after the operation, as the significantly SY Lee, et al / Analgesic Efficacy of Paracetamol 129
higher VAS scores showed, but the patients' overall degree 
of satisfaction regarding the pain control was not sig-
nificantly different, even in C Group, because the pain was 
considerably controlled in the times of 2 hours, 4 hours, 
and 6 hours after the operation by an additional admin-
istration of the analgesic to the most of the patients within 
1 hour after the operation.
    Since paracetamol, different from NSAIDs, does not 
cause  side  effects  such  as  platelet  function  declination, 
gastroin testinal bleeding, and the red uction of the renal 
function, it can be used on children for postoperative pain 
control. It is also a good substituent of NSAIDs for patients 
who are hypersensitive to NSAIDs, those who have declined 
renal function, and those have potential risk of a gastric 
ulcer or gastrointestinal bleeding. When it is used together 
with an opioid, it can reduce the dose of the opioid, as 
well as reduce the side effects of opioids, including respi-
ratory depression, sedation, and postoperative nausea and 
vomiting. 
    In addition, Bergenstock et al. [27] reported that, in 
contrast to the selective cyclooxygenase-II inhibitors, such 
as celecoxib, that delayed the fracture treatment, acet-
aminophen showed an analgesic effect without delaying the 
fracture treatment in the mouse experiment, implying that 
it can be also used for postoperative pain control of ortho-
paedic fracture patients.
    In this study, the occurrences of postoperative nausea 
and vomiting were 1 (5%), 1 (5%), 2 (10%), and 2 (10%) in 
C Group, K Group, P Group and PM Group, respectively. 
The occ urrence w as v ery rar e, consid ering that th yr oi-
dectom y normally shows a relativ ely high rate of post-
operative nausea and vomiting occurrence as compared to 
other  operations.  The  low  occurrence  of  postoperative 
nausea and vomiting is probably because, just before the 
end of the operation, an intravenous injection of ramose-
tron 0.3 mg was administered; this drug has a long action 
time and is a 5-HT3 receptor antagonist that has a high 
affinity to the 5-HT3 receptor. Fujii and Tanaka [28] re-
ported that ramosetron was effective in preventing post-
operative nausea and vomiting for the patients undergoing 
thyroidectomy. Other side effects, such as dizziness and 
sedation, were nearly nonexistent and not even 1 case of 
respiratory depression was found in C Group, K Group, P 
Group, and PM Group.
    The occurrence of headache as a postoperative side 
effect was 3 (15%), 4 (20%), 3 (15%), and 4 (20%) in C 
Group, K Group, P Group, and PM Group, respectively, and 
it was higher than other side effects. It is thought that 
such a frequent occurrence might be related with the thy-
r o i d e c t o m y  o p e r a t i o n  p o s i t i o n ,  e x t e n d i n g  t h e  n e c k  e x -
cessively to expose the operative part, and further study 
is required with respect to this.
    In conclusion, since a better analgesic effect was 
found in the 3 groups where the patients were injected with 
ketorolac 30 mg, paracetamol 1 g, and paracetamol 700 
mg and morphine 3 mg, respectively, at 30 minutes before 
the end of the thyroidectomy, in comparison with the con-
trol group, it is thought that paracetamol can be used for 
postoperative acute pain control, especially for the patients 
who cannot be medicated with NSAIDs, replacing ketorolac 
without any specific side effect.
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